Thank you for your interest in this study.  The purpose of the research is to speak with patients who have biliary tract cancer (BTC), also known as bile duct cancer or cholangiocarcinoma, to better understand the signs, symptoms, and impacts they are experiencing, and to get reactions to a questionnaire designed to assess symptoms and the impacts of these symptoms on patient with biliary tract cancer. Please answer the following eligibility questions to see if you are able to take part in an interview.  For eligible respondents, the research will take the form of a 75 to 90 minutes telephone interview. If you are eligible and take part in the interview, you will receive compensation for your time.

Any information you provide us with as part of the eligibility questions will be treated as confidential, it will be combined with feedback from others like yourself and will be stored in the United States. We will make sure that it is kept secured at all times. You will remain anonymous at all times and your information will not be passed to any other organization without your expressed permission.

This research is being conducted by IQVIA on behalf of a pharmaceutical sponsor.

If you are eligible to take part in the telephone interview after completing this survey you will be redirected to fill out a separate online consent form which provides more information on the study, your role in the study, compensation for your time, and your rights.

You have the right to withdraw at any time.  For more information about your rights, please see our privacy notice, which is available at www.iqvia.com/about-us/privacy.

If you have any questions, please contact Farah Toublan at Farah.Toublan@IQVIA.com or phone 929-270-8125.